Skip to main content
OpenTrials

Clinical trial condition

Neuroblastoma

Explore clinical trials studying Neuroblastoma. Study availability and eligibility vary by location and protocol.

492 public trials 88 recruiting studies
Refine in advanced search Browse all conditions

Neuroblastoma trial results

Enrolling by invitation

Risk Model for Metastasis Detection of Neuroblastoma

NCT06703944

Conditions
Bone Marrow Metastasis, Bone Metastases, Neoplasms, +11 more
Locations
  • Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
  • The Children's Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
  • Shenzhen Children's Hospital Shenzhen, China
View Trial Details
Active, not recruiting

PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy

NCT04837547

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +18 more
Locations
  • University of Florida Gainesville, Florida, United States
  • Levine Children's Hospital Charlotte, North Carolina, United States
  • Penn State Milton S. Hershey Medical Center and Children's Hospital Hershey, Pennsylvania, United States
View Trial Details
Active, not recruiting

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

NCT02650401

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Brain Diseases, +59 more
Locations
  • University of California San Diego La Jolla, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Egleston Children's Hospital at Emory University Atlanta Atlanta, Georgia, United States
View all 26 locations
View Trial Details
Active, not recruiting

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

NCT03210714

Conditions
Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +74 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 116 locations
View Trial Details
Active, not recruiting

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

NCT03698994

Conditions
Advanced Malignant Solid Neoplasm, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, +83 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 107 locations
View Trial Details
Active, not recruiting

Rapid Administration Pilot for Infusing Dinutuximab

NCT05421897

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Childrens Hospital of Colorado Aurora, Colorado, United States
  • Children's Hospital of Atlanta Atlanta, Georgia, United States
  • C.S. Mott Children's Hospital Ann Arbor, Michigan, United States
View Trial Details

Related conditions